Granite Point Capital Management’s Immunovant, Inc. Warrants expiring 12/18/2024 IMVTW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-250,000
Closed -$600K 143
2020
Q1
$600K Buy
+250,000
New +$600K 0.34% 56